| Bioactivity | BKM1644, an acyl-tyrosine bisphosphonate amide derivative, exhibits potent anti-cancer activity. BKM1644 effectively inhibits the proliferation of metastatic, castration-resistant prostate cance (mCRPC) cells. BKM1644 sensitizes mCRPC cells to Docetaxel (HY-B0011) and retards the bone metastatic growth of prostate cance[1]. |
| Name | BKM1644 |
| CAS | 1070966-96-9 |
| Formula | C34H37Cl2F5N2O9P2 |
| Molar Mass | 845.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shumin Zhang, et al. Inhibition of skeletal growth of human prostate cancer by the combination of docetaxel and BKM1644: an aminobisphosphonate derivative. Oncotarget. 2016 May 10;7(19):27489-98. |
BKM1644
CAS: 1070966-96-9 F: C34H37Cl2F5N2O9P2 W: 845.51
BKM1644, an acyl-tyrosine bisphosphonate amide derivative, exhibits potent anti-cancer activity. BKM1644 effectively inh
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.